Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis
- PMID: 20950074
- DOI: 10.1586/erp.10.60
Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis
Abstract
This article estimates the impact of walking speed (measured using the Timed 25-Foot Walk [T25FW]) on three economic outcomes: productivity (annual earnings), care burden (value per year) and quality of life (utility score). Empirical data are not available to directly measure these relationships. Therefore, this article develops indirect estimates by characterizing the impact of the T25FW on the Expanded Disability Status Scale (EDSS), and the impact of the EDSS on economic outcomes. Use of the EDSS as a bridge introduces uncertainty, which precludes robust quantification of the relationship between walking speed and economic outcomes. Nonetheless, the analysis provides plausible ranges for the magnitude of these relationships.
Similar articles
-
Costs and quality of life in multiple sclerosis in The Netherlands.Eur J Health Econ. 2006 Sep;7 Suppl 2:S55-64. doi: 10.1007/s10198-006-0378-6. Eur J Health Econ. 2006. PMID: 17310343
-
A corrected version of the Timed-25 Foot Walk Test with a dynamic start to capture the maximum ambulation speed in multiple sclerosis patients.NeuroRehabilitation. 2012;30(4):261-6. doi: 10.3233/NRE-2012-0754. NeuroRehabilitation. 2012. PMID: 22672939
-
Costs and quality of life of multiple sclerosis in Spain.Eur J Health Econ. 2006 Sep;7 Suppl 2:S65-74. doi: 10.1007/s10198-006-0381-y. Eur J Health Econ. 2006. PMID: 17310340
-
Contribution of impaired mobility to patient burden in multiple sclerosis.Curr Med Res Opin. 2010 Jan;26(1):109-19. doi: 10.1185/03007990903433528. Curr Med Res Opin. 2010. PMID: 19916707 Review.
-
Impact of mobility impairment on the burden of caregiving in individuals with multiple sclerosis.Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):433-40. doi: 10.1586/erp.10.34. Expert Rev Pharmacoecon Outcomes Res. 2010. PMID: 20482233 Review.
Cited by
-
Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosis.Int J MS Care. 2014 Fall;16(3):146-52. doi: 10.7224/1537-2073.2013-032. Int J MS Care. 2014. PMID: 25337057 Free PMC article.
-
Impact of mobility impairment on indirect costs and health-related quality of life in multiple sclerosis.PLoS One. 2013;8(1):e54756. doi: 10.1371/journal.pone.0054756. Epub 2013 Jan 23. PLoS One. 2013. PMID: 23355896 Free PMC article. Clinical Trial.
-
Effects of multidisciplinary inpatient rehabilitation on everyday life physical activity and gait in patients with multiple sclerosis.J Neuroeng Rehabil. 2024 May 28;21(1):88. doi: 10.1186/s12984-024-01383-0. J Neuroeng Rehabil. 2024. PMID: 38807215 Free PMC article.
-
Treatment of walking impairment in multiple sclerosis with dalfampridine.Ther Adv Neurol Disord. 2011 Mar;4(2):99-109. doi: 10.1177/1756285611403960. Ther Adv Neurol Disord. 2011. PMID: 21694807 Free PMC article.
-
Social and economic burden of walking and mobility problems in multiple sclerosis.BMC Neurol. 2012 Sep 18;12:94. doi: 10.1186/1471-2377-12-94. BMC Neurol. 2012. PMID: 22989365 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical